Role of B-1a cells in autoimmunity

Autoimmunity Reviews

Volumn 5, Issue 6, 2006, Pages 403-408

  Duan, Byian ^a   Morel, Laurence ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Antibodies; Autoimmunity; B 1a cells; CD5; Lupus

Indexed keywords

CD45 ANTIGEN; CELL SURFACE PROTEIN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; INTERLEUKIN 10; LEUKOSIALIN;

ANTIGEN PRESENTATION; APOPTOSIS; AUTOIMMUNITY; B LYMPHOCYTE; GENETIC LINKAGE; HUMAN; LUPUS ERYTHEMATOSUS; MOLECULAR RECOGNITION; NONHUMAN; PERITONEAL CAVITY; PLEURA CAVITY; PROTEIN EXPRESSION; REVIEW; SURFACE PROPERTY;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE;

EID: 33746503135     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2005.10.007     Document Type: Review

References (50)

1. Berland R., and Wortis H.H. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 20 (2002) 253-300
2. Kantor A.B., Merrill C.E., Herzenberg L.A., and Hillson J.L. An unbiased analysis of V-H-D-J(H) sequences from B-1a, B-1b, and conventional B cells. J Immunol 158 (1997) 1175-1186
3. Carroll M.C., and Prodeus A.P. Linkages of innate and adaptive immunity. Curr Opin Immunol 10 (1998) 36-40
4. O'Garra A., Chang R., Go N., Hastings R., Haughton G., Howard M., et al. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 22 (1992) 711-717
5. Mohan C., Morel L., Yang P., and Wakeland E.K. Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthritis Rheum 41 (1998) 1652-1662
6. Chan O.T., Madaio M.P., and Shlomchik M.J. The central and multiple roles of B cells in lupus pathogenesis. Immunology 169 (1999) 107-121
7. Tumang J.R., Hastings W.D., Bai C., and Rothstein T.L. Peritoneal and splenic B-1 cells are separable by phenotypic, functional, and transcriptomic characteristics. Eur J Immunol 34 (2004) 2158-2167
8. Won W.J., and Kearney J.F. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J Immunol 168 (2002) 5605-5611
9. Hippen K.L., Tze L.E., and Behrens T.W. CD5 maintains tolerance in anergic B cells. J Exp Med 191 (2000) 883-889
10. Haas K.M., Poe J.C., Steeber D.A., and Tedder T.F. B-1a and b-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 23 (2005) 7-18
11. Kantor A.B., and Herzenberg L.A. Origin of murine B cell lineages. Annu Rev Immunol 11 (1993) 501-538
12. Hardy R.R., and Hayakawa K. Cd5 B-Cells, A Fetal B-cell lineage. Adv Immunol 55 (1994) 297-339
13. Rothstein T.L. Cutting edge commentary: two B-1 or not to be one. J Immunol 168 (2002) 4257-4261
14. Cong Y.Z., Rabin E., and Wortis H.H. Treatment of murine CD5-B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. Int Immunol 3 (1991) 467-476
15. Haughton G., Arnold L.W., Whitmore A.C., and Clarke S.H. B-1 cells are made, not born. Immunol Today 14 (1993) 84-87
16. Clarke S.H., and Arnold L.W. B-1 cell development: evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation. J Exp Med 187 (1998) 1325-1334
17. Xu Z., Butfiloski E.J., Sobel E.S., and Morel L. Mechanisms of peritoneal B-1a cells accumulation induced by murine lupus susceptibility locus Sle2. J Immunol 173 (2004) 6050-6058
18. Chumley M.J., Dal Porto J.M., Kawaguchi S., Cambier J.C., Nemazee D., and Hardy R.R. A V(H)11V(kappa)9B cell antigen receptor drives generation of CD5(+) B cells both in vivo and in vitro. J Immunol 164 (2000) 4586-4593
19. Wang H.S., and Clarke S.H. Positive selection focuses the V(H)12B-cell repertoire towards a single B1 specificity with survival function. Immunol Rev 197 (2004) 51-59
20. Wardemann H., Boehm T., Dear N., and Carsetti R. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J Exp Med 195 (2002) 771-780
21. Baumgarth N., Herman O.C., Jager G.C., Brown L.E., Herzenberg L.A., and Chen J.Z. B-1 and B-2 cell-derived immunoglobulin M antibodies are non-redundant components of the protective response to influenza virus infection. J Exp Med 192 (2000) 271-280
22. Tumang J.R., Frances R., Yeo S.G., and Rothstein T.L. Cutting Edge: spontaneously Ig-secreting B-1 cells violate the accepted paradigm for expression of differentiation-associated transcription factors. J Immunol 174 (2005) 3173-3177
23. Kroese F.G., Butcher E.C., Stall A.M., Lalor P.A., Adams S., and Herzenberg L.A. Many of the IgA producing plasma cells in the murine gut are derived from self-replenishing precursors in the peritoneal cavity. Int Immunol 1 (1989) 75-84
24. Shaw P.X., Horkko S., Chang M.K., Curtiss L.K., Palinski W., Silverman G.J., et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 105 (2000) 1731-1740
25. Zhang M., Austen W.G., Chiu I., Alicot E.M., Hung R., Ma M.H., et al. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A 101 (2004) 3886-3891
26. Murakami M., Yoshioka H., Shirai T., Tsubata T., and Honjo T. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int Immunol 7 (1995) 877-882
27. Iizuka J., Katagiri Y., Tada N., Murakami M., Ikeda T., Sato N., et al. Introduction of an osteopontin gene confers the increase in B1 cell population and the production of anti-DNA autoantibodies. Lab Invest 78 (1998) 1523-1533
28. Reap E.A., Sobel E.S., Cohen P.L., and Eisenberg R.A. Conventional B-cells, not B-1-cells, are responsible for producing autoantibodies in Lpr-mice. J Exp Med 177 (1993) 69-78
29. Wen X.S., Zhang D.Q., Kikuchi Y., Yi J., Nakamura K., Yan X., et al. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus. Eur J Immunol 34 (2004) 2740-2749
30. Caligaris-Cappio F., Riva M., Tesio L., Schena M., Gaidano G., and Bergui L. Human normal CD5+ B lymphocytes can be induced to differentiate to CD5-B lymphocytes with germinal center features. Blood 73 (1989) 1259-1263
31. Mantovani L., Wilder R.L., and Casali P. Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors. J Immunol 151 (1993) 473-488
32. Murakami M., Tsubata T., Okamoto M., Shimizu A., Kumagai S., Imura H., et al. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 357 (1992) 77-80
33. Beebe A.M., Cua D.J., and Malefyt R.D. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 13 (2002) 403-412
34. Ishida H., Muchamuel T., Sakaguchi S., Andrade S., Menon S., and Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179 (1994) 305-310
35. Yin Z.N., Bahtiyar G., Zhang N., Liu L.Z., Zhu P., Robert M.E., et al. IL-10 regulates murine lupus. J Immunol 169 (2002) 2148-2155
36. Gunnarsson I., Nordmark B., Bakri A.H., Grondal G., Larsson P., Forslid J., et al. Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment-the role of IL-10 and HLA. Rheumatology 39 (2000) 886-893
37. Tyrrell-Price J., Lydyard P.M., and Isenberg D.A. The effect of interleukin-10 and of interleukin-12 on the in vitro production of anti-double-stranded DNA antibodies from patients with systemic lupus erythematosus. Clin Exp Immunol 124 (2001) 118-125
38. Ishikawa S., Sato T., Abe M., Nagai S., Onai N., Yoneyama H., et al. Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b(+)CD11c(+) dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J Exp Med 193 (2001) 1393-1402
39. Sato T., Ishikawa S., Akadegawa K., Ito T., Yurino H., Kitabatake M., et al. Aberrant B1 cell migration into the thymus results in activation of CD4 T cells through its potent antigen-presenting activity in the development of murine lupus. Eur J Immunol 34 (2004) 3346-3358
40. Hayakawa K., Hardy R.R., and Herzenberg L.A. Peritoneal Ly-1 B-cells-genetic-control, autoantibody production, increased lambda light chain expression. Eur J Immunol 16 (1986) 450-456
41. Hamano Y., Hirose S., Ida A., Abe M., Zhang D.Q., Kodera S., et al. Susceptibility alleles for aberrant B-1 cell proliferation involved in spontaneously occurring B-cell chronic lymphocytic leukemia in a model of New Zealand white mice. Blood 92 (1998) 3772-3779
42. Li N., Nakamura K., Jiang Y., Tsurui H., Matsuoka S., Abe M., et al. Gain-of-function polymorphism in mouse and human Ltk: implications for the pathogenesis of systemic lupus erythematosus. Hum Mol Genet 13 (2004) 171-179
43. Pers J.O., Jamin C., Lydyard P., Charreire J., and Youinou P. The H2 haplotype regulates the distribution of B cells into B-1a, B-1b and B-2 subsets. Immunogenetics 54 (2002) 208-211
44. Morel L., Rudofsky U.H., Longmate J.A., Schiffenbauer J., and Wakeland E.K. Polygenic control of susceptibility to murine systemic lupus-erythematosus. Immunity 1 (1994) 219-229
45. Mohan C., Morel L., Yang P., and Wakeland E.K. Genetic dissection of systemic lupus erythematosus pathogenesis-Sle2 on murine chromosome 4 leads to B cell hyperactivity. J Immunol 159 (1997) 454-465
46. Xu Z., Duan B., Croker B.P., Wakeland E.K., and Morel L. Genetic dissection of the murine lupus susceptibility locus Sle2: contributions to increased peritoneal B-1a cells and lupus nephritis map to different loci. J Immunol 175 (2005) 936-943
47. Li J., Liu Y., Xie C., Zhu J., Kreska D., Morel L., et al. Deficiency of type I interferon contributes to Sle2-associated component lupus phenotypes. Arthritis Rheum 52 (2005) 3063-3072
48. Jiang Y., Hirose S., Hamano Y., Kodera S., Tsurui H., Abe M., et al. Mapping of a gene for the increased susceptibility of B1 cells to Mott cell formation in murine autoimmune disease. J Immunol 158 (1997) 992-997
49. Atencio S., Amano H., Izui S., and Kotzin B.L. Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells. J Immunol 172 (2004) 4159-4166
50. Morel L., Croker B.P., Blenman K.R., Mohan C., Huang G., Gilkeson G., et al. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci U S A 97 (2000) 6670-6675